CannaMetrix, LLC

The quality of our team

CannaMetrix Leadership

HCSmith.jpg

Harold C. Smith, Ph.D. Founder and CEO

  • 32 years disease mechanism research, 15 years biotech drug development experience

  • Opinion leader in Epigenetics, 146 peer-reviewed publications

  • $16 M in Federal and Foundation Grant support, Bill and Melinda Gates funded Investigator

  • $6.8M raised as seed capital for OyaGen, Inc

  • Designed and established 6 laboratories since 1976 and directed operations at SUNY at Buffalo, Baylor College of Medicine, URMC Rochester and OyaGen, Inc  

CannaMetrix Team

Charles Smith, Ph.D.

Scientist

Picture4.png

Ryan Bennett, Ph.D.

Technical Consultant

Picture3.png

Andrew K Gonsalves,

General Council

David Yule, Ph.D.

URMC

GPCR consultant

Mitch O’Connell, Ph.D.

URMC

Gene Editing Consultant

Picture8.png

Luke Peppone, Ph.D.

URMC

Cannabis Clinical Trials

Consultant

​